جست‌وجوی استاد و پژوهشگر

Laura Fitzgerald Hall Allenمشاهده پروفایل

استادیار

• Radiation Oncology
• Cancer Treatment Technologies
• Breast Cancer Research
• +۴ مورد دیگر

Laura Fitzgerald Hall Allen, MD serves as an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine, Winston-Salem campus. She is board certified in radiation oncology and provides clinical cancer treatment services at the Atrium Health Wake Forest Baptist Hayworth Cancer Center in High Point, NC. Wake Forest University School of Medicine - Faculty Member Atrium Health Wake Forest Baptist - Clinical Provider Hayworth Cancer Center - Primary Practice Location Dr. Allen received her undergraduate education from Tulane University and earned her medical degree from the Medical College of Georgia School of Medicine in 1995. She completed her Internal Medicine residency at Emory Healthcare in 1996, followed by specialized training in Radiation Oncology at Memorial Sloan Kettering Cancer Center in 2000. Additional training was completed at Wake Forest University Baptist Medical Center in 2018. Dr. Allen specializes in comprehensive radiation oncology with expertise across multiple cancer types including breast, prostate, lung, and gastrointestinal cancers. Her technical proficiency spans External Beam Radiation, Image-Guided Radiotherapy, Intensity Modulated Radiotherapy (IMRT), and Volumetric Arc Radiotherapy (VMAT). She is deeply committed to patient-centered care, treating each patient as if they were family members, with the mission of bringing Wake Forest University School of Medicine's expertise into community practice settings. Her clinical approach emphasizes personalized treatment plans for patients navigating challenging cancer journeys. American Board of Radiology certification in Radiation Oncology Member of the American Society for Therapeutic Radiation and Oncology Dr. Allen maintains an exceptional patient satisfaction record with a 4.9/5.0 rating based on 81 verified patient reviews. Patients consistently praise her compassionate communication style, thorough explanations of medical conditions, attentive listening skills, and dedication to addressing concerns. Her practice accepts numerous insurance providers across the Wake Forest Baptist Health system, serving patients at the High Point location with office hours Monday through Friday from 8:00 AM to 5:00 PM.

Sebastiaan Breedveldمشاهده پروفایل

دانشیار

• Radiation Therapy
• Applied Mathematics
• Decision-Making
• +۳ مورد دیگر

Dr. Sebastiaan Breedveld is an Associate Professor in the Department of Radiation Oncology at Erasmus University Medical Center in Rotterdam, The Netherlands. His research focuses on improving radiation therapy through applied mathematics, multi-criteria optimization, and automated treatment planning. He developed the clinically implemented Erasmus-iCycle algorithm and leads projects like TROTS (Radiotherapy Optimisation Test Set). Education includes a PhD in Medical Physics (cum laude) from Erasmus University Rotterdam and an MSc in Applied Mathematics from Delft University of Technology. Research interests center on developing computational methods for real-time, personalized radiotherapy. Key areas include: Large-scale optimization for treatment planning Deep learning for instantaneous dose prediction Multi-criteria decision analysis for balancing treatment trade-offs Proton therapy and VMAT techniques High-performance computing applications Recent publications demonstrate strong focus on AI-driven automation in brachytherapy, IMPT robustness, and FLASH proton therapy. Work consistently addresses clinical translation of mathematical optimization. Significant scientific awards include: NWO Vidi Grant (2021) for INSTORAD project NWO Veni Grant (2016) MCDM Doctoral Dissertation Award (2015) Erasmus MC Efficiency Grant (2015) PhD with honors (2013) Leads research group supervising 2 post-docs, 11 PhD students, and numerous master/bachelor projects. Major grants support work in proton therapy optimization and automated planning systems. Developed TROTS dataset for benchmarking radiotherapy optimization algorithms and collaborates internationally through projects like BiCycle for automated brachytherapy planning.

• Radiation Oncology
• Cancer Research
• Clinical Trials
• +۲ مورد دیگر

Dr. Aileen Duffton serves as an Honorary Senior Lecturer within the School of Cancer Sciences at the University of Glasgow, based at the Beatson West of Scotland Cancer Centre in Glasgow. Her academic role centers on advancing radiation oncology through research and clinical collaboration, with a focus on optimizing radiotherapy delivery systems and patient-centered care pathways. Her research spans Radiation Oncology , Cancer Research (particularly rectal and prostate malignancies), Clinical Trials infrastructure, Medical Imaging integration, and Patient Experience optimization. Key investigations examine radiographer-led clinical trial coordination, patient information efficacy, and advanced practice models for radiation therapy technicians (RTTs), reflecting a commitment to workforce innovation in oncology services. Publication analysis (2018-2025) reveals consistent emphasis on stereotactic ablative radiotherapy (SABR), hypofractionation protocols, and in-silico treatment modeling. Her work bridges technical radiotherapy physics with pragmatic clinical implementation, notably through Scottish Radiographer Research Forum collaborations addressing real-world challenges in trial recruitment and dose verification. No scientific awards were documented in source materials. While her extensive co-authorship indicates active research mentorship, specific student advising records remain unreported. Collaborative networks prominently feature Scottish healthcare institutions including the Beatson Centre and University of Glasgow departments, with no dedicated lab or team structures specified.

Houra Mahmoudzadehمشاهده پروفایل

دانشیار

• Operations Research
• Healthcare Management
• Radiation Therapy Optimization
• +۳ مورد دیگر

Houra Mahmoudzadeh is an Associate Professor at the University of Waterloo, affiliated with groups such as Data Analytics, Applied Operations Research, and Healthcare. Her research focuses on optimization techniques applied to healthcare systems, particularly radiation therapy planning, robust decision-making under uncertainty, and pandemic-era staff scheduling. She specializes in developing advanced algorithms for IMRT treatment planning and addressing challenges in healthcare operations through mathematical modeling. Her work integrates robust optimization frameworks with clinical applications, emphasizing practical solutions for radiation therapy delivery, resource allocation in healthcare, and multi-objective decision-making. Key contributions include methodologies for inverse optimization in medical contexts, Pareto robust optimization strategies, and pandemic-specific staff scheduling models. Recent publications highlight innovations in dose-based constraint generation, light Pareto robust optimization, and effective budget of uncertainty formulations. Her research bridges theoretical operations research with real-world healthcare challenges, aiming to improve treatment efficacy and operational efficiency in medical settings.

Stephanie E. Combsمشاهده پروفایل

استاد

• Radiation Oncology
• Radiation Therapy
• Highly Conformal Radiation Therapy
• +۸ مورد دیگر

Prof. Dr. Stephanie E. Combs is a leading academic in Radiation Oncology at Technische Universität München (TUM), holding the position of Professor and Chair of the Department of Radiation Oncology. She also serves as the Dean of the TUM Faculty of Medicine since 2022. Her expertise spans highly conformal radiation therapy techniques (e.g., IMRT/IGRT/ART, proton, and carbon ion therapy), with a focus on brain and skull base tumors, pediatric oncology, gastrointestinal oncology, and biomarker-driven therapies. Prof. Combs studied medicine in Heidelberg and the United States, completed postdoctoral training in Heidelberg, and became Vice Chair of Radiation Oncology there before joining TUM in 2014. She has held leadership roles, including heading the TUM Senate from 2019 to 2022. Her research emphasizes precision medicine, radiation biology, and translational radiotherapy innovations. Her awards include the Basic/Translational Senior Science Award (2019), Robert Janker Award (2012), and multiple honors from German and international radiation oncology societies. Her work bridges clinical practice and research, with contributions to guidelines on target delineation for glioblastoma and skull base tumors. Prof. Combs’ publications focus on advancing radiation techniques, radiomics, and personalized therapy, with over 300 peer-reviewed articles. She leads initiatives in education, including a Master of Science program in Radiation Biology, and collaborates internationally in translational research.

Lee Johnsonمشاهده پروفایل

استاد

• Medical Physics
• Radiation Oncology
• Nuclear Chemistry
• +۴ مورد دیگر

Lee Johnson is a Professor and Director of Graduate Studies for Radiation Science College at the University of Kentucky, affiliated with the Radiation Medicine department. His work bridges nuclear physics and clinical applications, focusing on advancing radiation therapy techniques and medical imaging methodologies for cancer treatment. His academic foundation includes: B.S. in Chemical Engineering from the University of Kentucky (1979) B.A. in Science Education from the University of Kentucky (1981) Ph.D. in Nuclear Chemistry from the University of Kentucky (1993) Postdoctoral Training at Duke University Medical Center (1993-1995) Dr. Johnson's research spans medical physics, radiation oncology, and nuclear chemistry with significant contributions in SPECT imaging reconstruction, dosimetry for targeted radiotherapy, and grid therapy development. His early nuclear physics work on dysprosium isotopes evolved into clinical applications including real-time monitoring of blood flow during radiation therapy and carbon fiber couch optimization. His expertise in therapeutic radiological physics is evidenced by board certification from the American Board of Radiology. Analysis of his publication history reveals a strategic shift from fundamental nuclear research to applied medical physics. His most impactful work focuses on improving radiation delivery precision through innovations in grid block technology, IMRT protocols, and SPECT imaging techniques. The recurring themes across his career include quantification of radiopharmaceuticals, mitigation of treatment complications, and translation of physics principles into clinical oncology practice. His professional recognition includes: American Board of Radiology Certification in Therapeutic Radiological Physics (1999) As Director of Graduate Studies, Dr. Johnson shapes the Medical Physics Graduate Program curriculum and oversees resident training. His collaborative research with institutions like Duke University and the University of Kentucky's Chandler Medical Center demonstrates sustained engagement in funded projects addressing critical challenges in radiation oncology, though specific grant details aren't documented in the source material. He actively contributes to the Radiation Medicine department's tripartite mission through clinical research on surface dose mitigation, basic science investigations in radioisotope quantification, and translational work on real-time physiological monitoring during treatment. His leadership supports the department's equipment-intensive research environment including SPECT imaging systems and linear accelerator technology.

Angel Velarde Lopezمشاهده پروفایل

استاد

• Epidemiology
• Global Oncology
• Clinical Epidemiology
• +۷ مورد دیگر

Dr. Angel Velarde Lopez is a physician, researcher, and professor based in Guatemala, with dual expertise in medical physiology and clinical epidemiology. He holds a faculty position at the School of Medicine, University of San Carlos de Guatemala, and serves as the Department Director of Research at Liga Nacional Contra el Cáncer. He earned a Master of Science in Clinical Epidemiology from the University of Pennsylvania through an NIH scholarship, mentored by Dr. Brian L. Strom. Medical Degree: University of San Carlos School of Medicine, Guatemala MSCE: University of Pennsylvania, NIH Scholarship Continuing Education: Harvard School of Medicine (Electrocardiography) His research focuses on global oncology , particularly cancer epidemiology, radiotherapy access, and health disparities in low- and middle-income countries. He has led and contributed to studies on breast, colon, liver, and brain cancers, with a strong emphasis on improving treatment quality and equity. His work in radiotherapy modernization in Guatemala — transitioning from cobalt-60 to linear accelerators — has been widely published and recognized as a model for LMICs. Dr. Velarde’s recent publications reveal a consistent focus on cancer care delivery , predictive modeling (e.g., Lynch Syndrome), antimicrobial resistance , and implementation science . His collaborative research spans institutions in the U.S., Guatemala, and Taiwan, reflecting a transnational approach to global health challenges. His work often integrates clinical medicine with public health and health systems research. Scientific Awards: NIH Scholarship for MSCE at University of Pennsylvania Dr. Velarde has been actively involved in mentoring and global health education initiatives. He has contributed to simulation-based medical training and has worked on projects funded by international collaborations, including partnerships with the University of Pennsylvania’s Center for Global Health. While no formal list of advisees is provided, his leadership roles suggest active involvement in training future physicians and researchers. He is a key figure in advancing cancer research and treatment in Guatemala, working at the intersection of clinical practice, epidemiology, and health policy. His leadership in radiotherapy quality improvement and cancer epidemiology underscores his role in building sustainable oncology infrastructure in resource-limited settings.

Wade L. Thorstadمشاهده پروفایل

استاد

• Head and Neck Oncology
• Radiation Therapy
• Oropharyngeal Squamous Cell Carcinoma
• +۳ مورد دیگر

Wade L. Thorstad, MD is a Professor of Radiation Oncology at Washington University School of Medicine, where he serves as Chief of the Head and Neck Cancer Service and Co-leader of the Siteman Cancer Center Head & Neck Tumor Center. With over 25 years of experience, Dr. Thorstad is a board-certified specialist in Radiation Oncology and Nuclear Medicine who has made significant contributions to head and neck cancer treatment. Dr. Thorstad received his BS in Biophysics from Trinity University (1986) and his MD from University of Texas Medical School (1991). He completed his residency in Radiation Oncology at Loyola University Medical Center (1995), a residency in Nuclear Medicine at Duke University Medical Center (1997), and a fellowship in Radiation Oncology at the Mayo Clinic (1998). He joined the Washington University faculty in 2000. Dr. Thorstad's research focuses on improving Head and Neck radiation therapy through intensity modulated radiation therapy (IMRT), studying patterns of failure, and developing treatment guidelines based on efficacy and toxicity. He integrates combined modality therapy using minimally invasive surgical techniques like transoral laser microsurgery (TLM) and transoral robotic surgery (TORS) with IMRT to maximize efficacy while minimizing toxicity. His work also incorporates patient-reported outcomes, anatomic and molecular imaging, and biomarkers to individualize cancer treatment. With over 167 publications and 10,517 citations, Dr. Thorstad's research spans head and neck oncology, HPV-related oropharyngeal cancer, radiation therapy techniques, and cancer imaging. His recent work emphasizes AI applications in cancer diagnosis, treatment outcomes for HPV-positive cancers, and personalized approaches to radiation therapy. Dr. Thorstad has received the Teacher of the Year Award from the Department of Radiation Oncology at Washington University (2011). His clinical expertise includes head and neck oncology, thoracic cancer, nuclear oncology, and PET imaging. As Chief of the Head and Neck Cancer Service and Co-leader of the Siteman Head and Neck Tumor Center, Dr. Thorstad leads a multidisciplinary team focused on advancing cancer care through research and clinical innovation. His work involves collaboration across radiation oncology, surgery, medical oncology, and pathology to develop comprehensive treatment approaches for head and neck cancer patients.

• Radiation Oncology
• Stereotactic Radiosurgery
• Breast Cancer
• +۳ مورد دیگر

Dr. Jason Ye is an Associate Professor of Clinical Radiation Oncology at the Keck School of Medicine of USC and Director of Clinical Operations at USC Norris Comprehensive Cancer Center. He specializes in advanced radiation treatments including stereotactic body radiotherapy (SBRT), intensity modulated radiation therapy (IMRT), and CNS stereotactic radiosurgery (SRS). His clinical expertise focuses on breast cancer, lung cancer, and central nervous system tumors. Dr. Ye leads research in radiation oncology techniques and has published on topics ranging from technical innovations in radiotherapy to clinical outcomes in cancer treatment. His recent work demonstrates a focus on improving precision in radiation therapy and developing standardized protocols for cancer imaging.

• Healthcare Innovation
• Vulnerable Populations Care
• Medical Informatics
• +۴ مورد دیگر

Dr. David Rosenthal is an Assistant Professor of Medicine (General Internal Medicine) at Yale School of Medicine. He is affiliated with the Errera Community Care Center and serves as a Healthcare Venture Partner at AlleyCorp. His clinical and research focus includes care for vulnerable populations, particularly veterans experiencing homelessness, and innovative healthcare technologies such as mobile applications for buprenorphine treatment. Dr. Rosenthal has held leadership roles in the Homeless Patient Aligned Care Team (HPACT) and contributed to national initiatives addressing veteran homelessness. Education: B.A. in Visual and Environmental Studies from Harvard University (2001) M.D. from Northwestern University Feinberg School of Medicine (2008) Medical residency at Brigham and Women's Hospital (2012) Research Interests: Dr. Rosenthal's work bridges clinical care innovation and healthcare equity, with a focus on: Technology-driven solutions for underserved populations Medical-legal partnerships and policy advocacy Radiation oncology advancements for head/neck cancers His research has led to impactful programs like the VA HPACT model and the Buprenorphine Home Induction Mobile App. Professional Contributions: He holds advisory roles with AlleyCorp, 4Catalyzer, and the New Haven Regional Biosciences Collaborative. His leadership in medical education includes co-directing Yale's Professional Responsibility and Introduction to the Profession courses. Awards: Aspen Institute Health Innovators Fellowship (2022) Proclamation from New Haven Mayor for pandemic response (2020) Roivant Science Prize (2018) Labs/Teams: Co-director of the Yale CBIT (Center for Biomedical Innovation and Technology) and member of the Errera Community Care Center leadership team.

• Radiation Oncology
• Medical Physics
• Image-Guided Radiation Therapy
• +۳ مورد دیگر

Srijit Kamath serves as Assistant Professor of Therapeutic Radiology at Yale School of Medicine, Yale University, with additional responsibility as Regional Chief Physicist overseeing operations at Trumbull Radiation Oncology, Smilow Cancer Hospital Care Center at Greenwich, and Griffin Hospital Lawrence and Memorial Cancer Center. His clinical leadership ensures physics standards across Yale's integrated cancer care network including Smilow Cancer Hospital and Yale Gamma Knife Center. His academic foundation includes: Medical Physics Residency, University of Florida (2010) PhD, University of Florida (2005) MS, University of Florida (2000) Dr. Kamath's research program centers on computational optimization of radiation therapy delivery, with seminal contributions to intensity-modulated radiation therapy (IMRT) field splitting algorithms, multileaf collimator sequencing, and deformable image registration. His work addresses critical challenges in treatment delivery efficiency while maintaining dosimetric accuracy, particularly for large-field treatments where conventional approaches risk underdosage at field junctions. He has pioneered methods to eliminate tongue-and-groove effects and optimize feathering techniques for seamless dose distributions. Analysis of his 15 most recent publications (2003-2011) reveals a consistent trajectory from foundational work on leaf sequencing algorithms to sophisticated solutions for deformable image registration and CBCT system optimization. His comparative studies of XVI and OBI CBCT systems established critical benchmarks for image quality in radiation therapy guidance, while his field-splitting algorithms remain clinically implemented for complex treatment geometries. The research demonstrates exceptional focus on translating computational advances into practical clinical workflows. No scientific awards or honors were documented in the available information. As Regional Chief Physicist, Dr. Kamath directs medical physics services across multiple community cancer centers, ensuring compliance with safety standards and optimal implementation of advanced techniques like stereotactic body radiation therapy (SBRT). While student advising activities aren't specified, his role in Yale's residency training program involves mentoring medical physics residents through clinical rotations. The absence of grant documentation suggests primary focus on clinical service and technical innovation rather than externally funded research. He operates within Yale's comprehensive radiation oncology infrastructure, collaborating with multidisciplinary teams at Smilow Cancer Hospital and affiliated centers to integrate advanced imaging and treatment technologies. His work directly supports the clinical mission of delivering precision radiation therapy through physics-driven quality assurance and process optimization.

Fatih Demircioğluمشاهده پروفایل

دانشیار

• Radiation Oncology
• Breast Cancer
• Central Nervous System Tumors
• +۳ مورد دیگر

Assoc. Prof. Dr. Fatih Demircioğlu is a faculty member in the Radiation Oncology Department at Istanbul Okan University Hospital, where he has been serving since July 2023. Previously, he worked at Kartal Dr. Lütfi Kırdar Training and Research Hospital (2013-2023) and Rize Training and Research Hospital (2010-2013). He completed his medical degree at Ondokuz Mayıs University (1998-2005) and specialized in Radiation Oncology at Gazi University (2005-2010), becoming an Associate Professor in 2021. His research focuses on: Breast Cancer : Radiotherapy techniques and toxicity management Central Nervous System Tumors : Stereotactic radiotherapy and salvage treatments Lung & Head-Neck Cancers : Re-irradiation strategies and outcome optimization Prostate Cancer : Precision radiotherapy approaches Radiation Safety : Dosimetric evaluations and staff protection protocols His 15 most recent publications (2023-2014) demonstrate strong focus on radiotherapy outcomes across multiple cancer types, with consistent themes in: Advanced techniques like IMRT, stereotactic radiosurgery, and CyberKnife Organ-sparing approaches (e.g., carotid preservation in laryngeal cancer) Palliative care integration for metastatic disease Imaging-guided radiotherapy planning (MRI applications) Treatment toxicity mitigation strategies He has taught graduate courses including Radiation Oncology Basic Principles and Central Nervous System Tumors Radiotherapy . His editorial contributions include peer review for oncology journals, and he holds certifications in radiotherapy physics, clinical research ethics, and stereotactic techniques from institutions like TROD and ESMO.

• Clinical Trial Development
• Prognostic Markers
• Radiation Sensitizers
• +۵ مورد دیگر

David K. Gaffney is a Professor in the Department of Radiation Oncology at the University of Utah and serves as Senior Director for Clinical Research at the Huntsman Cancer Institute . He holds the J Robert and Ann K Stewart Endowed Professorship and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphomas. Education: PhD in Biochemistry (1990), MD (1992) - Medical College of Wisconsin Residency - University of Utah School of Medicine Internship - LDS Hospital, Salt Lake City Dr. Gaffney’s research focuses on clinical trial development , prognostic markers , radiation sensitizers , and secondary cancers . His work addresses improving survival and quality of life for cancer patients through optimized radiation protocols and global health initiatives. Recent publications emphasize brachytherapy for cervical cancer, IMRT applications, and financial implications of treatment regimens. He chairs the Clinical Research Executive Committee at Huntsman Cancer Institute and contributes as a Senior Editor for journals like International Journal of Gynecologic Cancer . Dr. Gaffney actively collaborates with international organizations such as the Gynecologic Cancer Intergroup and has led guidelines for cervical and endometrial cancer staging and treatment.

Ann C. Raldowمشاهده پروفایل

دانشیار

• Radiation Oncology
• Gastrointestinal Cancer
• Hematologic Malignancies
• +۵ مورد دیگر

Ann C. Raldow is an Associate Professor in the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA. She specializes in treating gastrointestinal and hematologic malignancies using advanced radiation techniques like IMRT, MRgRT, and SBRT. Princeton University (BA in Molecular Biology) Yale University School of Medicine (MD) Harvard T.H. Chan School of Public Health (MPH) Her research focuses on therapeutic decision-making, cost-effective care, and quality-of-life assessment in cancer treatment. Recent publications emphasize stereotactic radiation applications, health economics, and multidisciplinary approaches to GI and prostate cancers. Super Doctors® Southern California Rising Stars (2019-2024) Top Doctors, Los Angeles Magazine (2021) Dr. Raldow is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center. She is board-certified in Radiation Oncology (American Board of Radiology, 2017) and contributes to clinical trials involving rectal and pancreatic cancer treatments.

Edvard Abelمشاهده پروفایل

پژوهشگر

• Radiation Oncology
• Cancer Treatment
• Quality of Life in Cancer Patients
• +۳ مورد دیگر

Edvard Abel is affiliated with the Department of Oncology at the University of Gothenburg, where he conducts research focused on radiation oncology and quality-of-life outcomes in cancer patients. He defended his doctoral thesis in oncology in 2022, titled *"Effects on quality of life of new radiotherapy techniques in treatment of head and neck cancer"*. His work emphasizes improving patient outcomes through advanced radiotherapy techniques, precision medicine, and clinical trial design. Dr. Abel's research interests include genomics-guided therapy, neurological effects of radiotherapy, and optimizing patient care through interdisciplinary collaboration. His publications span topics such as biomarker-driven clinical trials (MEGALiT trial), international precision medicine initiatives (PCM4EU/PRIME-ROSE), and longitudinal studies on long-term quality of life in head and neck cancer survivors. His research has been published in journals like *Acta Oncologica*, *Advances in Radiation Oncology*, and *Journal of Clinical Oncology*. While no specific awards are listed, his contributions highlight advancements in oncology treatment protocols and patient-centered care. Dr. Abel collaborates with Sahlgrenska University Hospital and contributes to clinical research teams focused on oncology innovation. His work underscores a commitment to bridging translational research with clinical practice to enhance cancer treatment efficacy and patient well-being.